AtriCure (ATRC) Misses Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
AtriCure Reports Fourth Quarter 2021 and Full Year 2021 Financial Results
February 15, 2022 4:01 PM ESTMASON, Ohio,--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... More

